Received Jun 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 4y2p4 | IM / RA |
Site: Redness at Injection Site-Mild, Systemic: permanent skin discoloration at injection site-Mild, Additional Details: patient came in to pharmacy on 6.4.25 for pfizer covid-19 vaccine and stated that he experienced permanent discoloration at injection site after having mild redness